4.6 Article

The Effect of a DNA Repair Gene on Cellular Invasiveness: Xrcc3 Over-Expression in Breast Cancer Cells

Journal

PLOS ONE
Volume 6, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0016394

Keywords

-

Funding

  1. Weekend to End Breast Cancer-Jewish General Hospital Foundation
  2. CIHR [MOP-86519]
  3. Canadian Breast Cancer Research Alliance

Ask authors/readers for more resources

Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage induced by chemotherapeutic agents such as cisplatin. More recently, based on the analysis of genome expression profiling, it was proposed that over-expression of DNA repair genes enhances the invasive behaviour of tumour cells. In this study we present experimental evidence utilizing functional assays to test this hypothesis. We assessed the effect of the DNA repair proteins known as X-ray complementing protein 3 (XRCC3) and RAD51, to the invasive behavior of the MCF-7 luminal epithelial-like and BT20 basal-like triple negative human breast cancer cell lines. We report that stable or transient overexpression of XRCC3 but not RAD51 increased invasiveness in both cell lines in vitro. Moreover, XRCC3 over-expressing MCF7 cells also showed a higher tumorigenesis in vivo and this phenotype was associated with increased activity of the metalloproteinase MMP-9 and the expression of known modulators of cell-cell adhesion and metastasis such as CD44, ID-1, DDR1 and TFF1. Our results suggest that in addition to its' role in facilitating repair of DNA damage, XRCC3 affects invasiveness of breast cancer cell lines and the expression of genes associated with cell adhesion and invasion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Genetics & Heredity

Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application

Kateryna Kratzer, Landon J. Getz, Thibaut Peterlini, Jean-Yves Masson, Graham Dellaire

Summary: Gene therapy for genetic diseases has gained increased attention, but faces technical challenges and ethical barriers. Current research is primarily focused on improving gene therapy and gene editing techniques, with less emphasis on the timing and rationale for using such technology.

HUMAN GENETICS (2022)

Article Biochemistry & Molecular Biology

RAD51 protects against nonconservative DNA double-strand break repair through a nonenzymatic function

Ayeong So, Elodie Dardillac, Ali Muhammad, Catherine Chailleux, Laura Sesma-Sanz, Sandrine Ragu, Eric Le Cam, Yvan Canitrot, Jean Yves Masson, Pauline Dupaigne, Bernard S. Lopez, Josee Guirouilh-Barbat

Summary: Selection of DSB repair pathway is crucial for genetic stability. RAD51 plays a role in preventing nonconservative repair by controlling the second step of the repair process in human cells. RAD51's DNA binding ability is required for inhibiting SSA/A-EJ, not GC.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal

Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Janusz Menkiszak, Jeanna McCuaig, Kelly Metcalfe, William D. Foulkes, Susan L. Neuhausen, Sophie Sun, Beth Y. Karlan, Andrea Eisen, Nadine Tung, Olufunmilayo Olopade, Fergus J. Couch, Tomasz Huzarski, Leigha Senter, Louise Bordeleau, Christian F. Singer, Charis Eng, Robert Fruscio, Tuya Pal, Ping Sun, Steven A. Narod

Summary: The study suggests that bilateral oophorectomy is unlikely to determine the risk of breast cancer in BRCA1 mutation carriers, but it should be offered at age 35 to reduce the risk of ovarian and fallopian tube cancer.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract

Felix K. F. Kommoss, Basile Tessier-Cloutier, Leora Witkowski, Erna Forgo, Christian Koelsche, Martin Kobel, William D. Foulkes, Cheng-Han Lee, David L. Kolin, Andreas von Deimling, Brooke E. Howitt

Summary: SWI/SNF complex deficiency is common in various cancers, especially in the gynecologic tract. Despite their similar morphology, UDEC, SDUS, and SCCOHT have distinct DNA methylation signatures. Our study highlights the importance of cellular context in determining the epigenetic landscape and suggests that methylation profiling may be a useful diagnostic tool in undifferentiated, SWI/SNF-deficient cancers.

JOURNAL OF PATHOLOGY (2022)

Editorial Material Materials Science, Ceramics

Comment on Self-diffusion in high-purity α-Al2O3: Comparison of Ti-doped, Mg-doped and undoped single crystals P. Fielitz, S. Ganschow, K. Klemens, and G. Borchardt, J. Eur. Ceram. Soc., 41, (2021), 663-668

A. H. Heuer, M. W. Finnis, W. M. C. Foulkes, A. P. Chen

Summary: This paper comments on recent observations of O and Al self-diffusion in single-crystal sapphire with variable doping concentrations of Mg and Ti. The study suggests that the null effect of aliovalent doping on oxygen diffusivity may be attributed to dopant evaporation near the surface due to extensive heat treatment, whereas an effect on Al diffusivity is still discernible. Furthermore, buffering mechanisms are proposed to be ultimately responsible for modest increases of self-diffusion with respect to dopant concentrations.

JOURNAL OF THE EUROPEAN CERAMIC SOCIETY (2022)

Article Geriatrics & Gerontology

Scene memory and hippocampal volume in middle-aged women with early hormone loss

Nicole J. Gervais, Laura Gravelsins, Alana Brown, Rebekah Reuben, Laurice Karkaby, Elizabeth Baker-Sullivan, Leanne Mendoza, Claire Lauzon, Anne Almey, William D. Foulkes, Marcus Q. Bernardini, Michelle Jacobson, Lea Velsher, M. Natasha Rajah, Rosanna K. Olsen, Cheryl Grady, Gillian Einstein

Summary: This study found that early midlife bilateral salpingo-oophorectomy (BSO) may be associated with reduced medial temporal lobe structure and function in women, increasing the risk of dementia. Hippocampal subfield volume may be useful for identifying early midlife changes in women at elevated risk for dementia.

NEUROBIOLOGY OF AGING (2022)

Letter Oncology

Comment on: Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents

Flavia Watusi de Faria, Elvis Terci Valera, Carla Renata Pacheco Donato Macedo, Erika Furtado Azevedo, Ana Glenda S. Vieira, Gisele E. Martins, Acimar Goncalves da Cunha Junior, Maristella Bergamo Francisco dos Reis, William D. Foulkes, Luiz Fernando Lopes

PEDIATRIC BLOOD & CANCER (2022)

Article Pathology

PRAME protein expression in DICER1-related tumours

Paul S. Thorner, Anne-Sophie Chong, Javad Nadaf, Naciba Benlimame, Paula Marrano, Rose Chami, Lili Fu, William D. Foulkes

Summary: This study found that PRAME expression occurs in two-thirds of DICER1-related malignancies and may be a marker for the progression of certain DICER1-related lesions, such as PPB and CN. PRAME expression in some tumors, such as RMS, appears to be an intrinsic feature of the tumor, rather than specifically related to DICER1 pathogenic variants.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2022)

Article Biology

KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity

Marjorie Fournier, Amelie Rodrigue, Larissa Milano, Jean-Yves Bleuyard, Anthony M. Couturier, Jacob Wall, Jessica Ellins, Svenja Hester, Stephen J. Smerdon, Laszlo Tora, Jean-Yves Masson, Fumiko Esashi

Summary: The tumour suppressor PALB2 stimulates homologous recombination (HR) repair of DNA damage and protects active genes during DNA replication. Acetylation of the 7K-patch within the PALB2 chromatin association motif (ChAM) by KAT2A/2B enhances PALB2's association with nucleosomes. DNA damage triggers deacetylation of ChAM and increases PALB2's mobility. Mutations in the 7K-patch affect PALB2's chromatin binding, leading to defects in RAD51 foci formation and decreased cell survival.

ELIFE (2022)

Correction Pathology

PRAME protein expression in DICER1-related tumours (vol 8, pg 294, 2022)

Paul S. Thorner, Anne-Sophie Chong, Javad Nadaf, Naciba Benlimame, Paula Marrano, Rose Chami, Lili Fu, William D. Foulkes

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2022)

Review Genetics & Heredity

miRNA biogenesis and inherited disorders: clinico-molecular insights

Dylan Pelletier, Barbara Rivera, Marc R. Fabian, William D. Foulkes

Summary: MicroRNAs (miRNAs) are crucial for gene expression regulation, and their biogenesis depends on specific genes such as DROSHA, DGCR8, DICER1, and AGO1/2. Germline pathogenic variants (GPVs) in these genes lead to different genetic syndromes with diverse clinical manifestations. DICER1 GPVs are associated with tumor predisposition, while recent studies have shed light on the clinical consequences of GPVs in DGCR8, AGO1, and AGO2. This review provides an up-to-date summary on how GPVs in miRNA biogenesis genes affect miRNA biology and contribute to clinical manifestations.

TRENDS IN GENETICS (2023)

Article Biochemistry & Molecular Biology

DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility

Dylan Pelletier, Anne-Laure Chong, Mona Wu, Leora Witkowski, Sophie Albert, Nelly Sabbaghian, Marc R. Fabian, William D. Foulkes

Summary: The endoribonuclease DICER1 is crucial in microRNA biogenesis, generating mature single-stranded miRNAs by cleaving pre-miRNA stem-loops. Pathogenic variants in DICER1 result in DICER1 tumor predisposition syndrome (DTPS), a childhood-onset tumor susceptibility disorder. Germline DICER1 missense variants in the Platform domain have been found in patients with tumors associated with DTPS, which impair miRNA biogenesis by preventing DICER1 from producing mature miRNAs and binding to pre-miRNA stem-loops.

NAR CANCER (2023)

Review Oncology

A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma

Claire Freycon, Philip J. Lupo, Leora Witkowski, Crystal Budd, William D. Foulkes, Catherine Goudie

Summary: This systematic review found that some patients with FOXO1 fusion-positive ARMS have pathogenic/likely pathogenic variants in cancer predisposing genes, but the causal relationship between CPS and FP-ARMS could not be determined. Only one patient was diagnosed with a cancer predisposition syndrome known to be associated with rhabdomyosarcoma. Clinicians cannot solely rely on FOXO1 fusion status to distinguish patients with/without CPS.

PEDIATRIC BLOOD & CANCER (2023)

Article Public, Environmental & Occupational Health

Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina

Ayelen T. Eberhardt, Melina Simoncini, Carlos Pina, German Galoppo, Virginia Parachu-Marco, Andrea Racca, Sofia Arce, Evangelina Viotto, Florencia Facelli, Florencia Valli, Cecilia Botto, Leonardo Scarpa, Celina Junges, Cintia Palavecino, Camila Beccaria, Diego Sklar, Graciela Mingo, Alicia Genolet, Monica Munoz de Toro, Hugo Aimar, Veronica Marignac, Juan Carlos Bossio, Gustavo Armando, Hugo Fernandez, Pablo M. Beldomenico

Summary: The Omicron variant of SARS-CoV-2 is more infectious and has immune escape capabilities compared to previous variants, leading to a surge in COVID-19 cases worldwide. Despite a high vaccination and infection rate in Santa Fe city, Argentina, the arrival of Omicron caused the largest wave of COVID-19 experienced in the city. A study conducted prior to the arrival of Omicron showed that a majority of sampled individuals had acquired immunity against COVID-19, but antibody levels varied depending on the vaccine platform received, previous COVID-19 infection, and time since last antigen exposure. A follow-up study provided real-world evidence that pre-wave antibody titres were strongly associated with reduced COVID-19 incidence and severity of symptoms during the wave. Additionally, receiving a vaccine shot during the follow-up period significantly reduced the risk of COVID-19.

EPIDEMIOLOGY AND INFECTION (2022)

Article Oncology

Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326*Variant in BRCA2

Wojciech Kluzniak, Agata Szymiczek, Amelie Rodrigue, Dominika Wokolorczyk, Bogna Rusak, Klaudia Stempa, Tomasz Huzarski, Jacek Gronwald, Jan Lubinski, Neda Zamani, Shiyu Zhang, Jean-Yves Masson, Steven A. Narod, Cezary Cybulski, Mohammad R. Akbari

Summary: In the Polish population, the low-penetrance BRCA2 p.K3326* variant is associated with increased breast cancer risk only in individuals homozygous for the T allele of the ALDH2 rs10744777 variant, suggesting an interaction between these two variants.

JCO PRECISION ONCOLOGY (2022)

No Data Available